Little Green Pharma (ASX:LGP) Common Stock: A$102.65 Mil (As of Mar. 2026)


What is Little Green Pharma Common Stock?

Little Green Pharma ASX:LGP +4.55% Common Stock is A$102.65 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's quarterly common stock increased from Mar. 2025 (A$102.23 Mil) to Sep. 2025 (A$102.62 Mil) and increased from Sep. 2025 (A$102.62 Mil) to Mar. 2026 (A$102.65 Mil).

Little Green Pharma's annual common stock increased from Mar. 2024 (A$101.93 Mil) to Mar. 2025 (A$102.23 Mil) and increased from Mar. 2025 (A$102.23 Mil) to Mar. 2026 (A$102.65 Mil).

Little Green Pharma Common Stock Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma Common Stock Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial 86.20 101.18 101.93 102.23 102.65

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.93 101.98 102.23 102.62 102.65

Little Green Pharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of A$102.65 Mil mean?
Little Green Pharma (ASX:LGP) has a Common Stock of A$102.65 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Little Green Pharma and its competitors.
Is Little Green Pharma's Common Stock too high?
Little Green Pharma's current Common Stock is A$102.65 Mil.
How does Little Green Pharma's Common Stock compare to ZTS and UTHR?
Little Green Pharma's Common Stock of A$102.65 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Little Green Pharma and its competitors. Little Green Pharma's current Common Stock is A$102.65 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.17, compared to a current price of A$0.07 — trading 59.4% below its estimated fair value. The current Common Stock is A$102.65 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Common Stock is A$102.65 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).